These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 302825)

  • 1. Rabbit anti-mouse thymocyte antibody as an adjuvant in the preparation of further anti-thymocyte sera.
    Lai T; Symes MO
    Immunology; 1977 Sep; 33(3):387-90. PubMed ID: 302825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative effectiveness of rabbit anti-mouse thymocyte sera in potentiating the survival of mouse skin or tumour allografts made across the H-2 barrier.
    Lai T; Symes MO
    Immunology; 1976 Jul; 31(1):21-6. PubMed ID: 800400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic aspects of tumor induction by mammary tumor virus.
    Blair PB
    J Natl Cancer Inst; 1972 Apr; 48(4):1121-4. PubMed ID: 4336876
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular cooperation during in vivo anti-hapten antibody responses. III. The helper cell activity of activated thymocytes, of spleen cells treated with anti-theta serum, and of spleen cells from anti-thymocyte serum-treated or adult thymectomized donors.
    Janeway CA
    J Immunol; 1975 Apr; 114(4):1408-14. PubMed ID: 1078836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of in vitro, immunosuppressive and clinical effects of goat and horse anti-human thymocyte globulin in Macaca monkeys.
    Kelly GE; Sheil AG; Mears DC
    Clin Exp Immunol; 1973 Apr; 13(4):585-94. PubMed ID: 4197827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An attempt at isolation and partial characterization of specific antibodies from antithymocyte serum.
    Fricová V; Hrubá A; Paluska E; Holdová J
    Folia Biol (Praha); 1979; 25(6):353-61. PubMed ID: 42567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
    Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
    J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of metastasis by antithymocyte globulin.
    James SE; Salsbury AJ
    Cancer Res; 1974 Feb; 34(2):367-70. PubMed ID: 4544019
    [No Abstract]   [Full Text] [Related]  

  • 10. Cancer in immunosuppressed experimental animals and human patients.
    Allison AC
    Johns Hopkins Med J Suppl; 1974; 3():341-51. PubMed ID: 4370940
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppressive activity of rabbit anti-mouse thymocyte sera produced with subcellular fractions (author's transl)].
    Liabeuf A; Elie R; Lamoureux G
    Ann Immunol (Paris); 1973 May; 124(2):197-207. PubMed ID: 4583647
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the decline in immunosuppressive potency of rabbit anti-mouse thymocyte sera raised by repeated immunization of the same rabbit.
    Ponsford FM; Symes MO
    Folia Biol (Praha); 1971; 17(4):227-35. PubMed ID: 5002373
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunofluorescent assay of anti-human thymocyte globulin as a means of correlating "in vitro" and "in vivo" activity.
    Ablin RJ; Morrell RM
    Dev Biol Stand; 1974; 27():223-8. PubMed ID: 4618534
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-thymocyte serum and bone marrow transplantation. I. Effect of anti-mouse thymocyte serum on hematopoietic stem cells.
    Kodo H; Harada M; Hattori K
    Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):183-9. PubMed ID: 6344533
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific T cell-dependent, antigen-antibody mediated suppression of macrophages: abrogation by nonspecifically stimulated T cells.
    Rao VS; Mokyr MB; Gershon RK; Mitchell MS
    J Immunol; 1977 Jun; 118(6):2117-24. PubMed ID: 325141
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on heterologous antilymphocyte and antithymocyte sera. V. Loss or retention of immunosuppressive activity after absorption with sheep erythrocytes.
    Barth RF; Singla O
    J Immunol; 1972 Nov; 109(5):1003-8. PubMed ID: 4562422
    [No Abstract]   [Full Text] [Related]  

  • 18. [Formation of antibodies against the antigen-recognizing receptors of T-lymphocytes in a syngenous system].
    Nesterenko VG; Cherniakhovskaia IIu
    Biull Eksp Biol Med; 1977 Dec; 84(12):693-5. PubMed ID: 304363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 20. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.